Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

• প্রধান লেখক: Umair Ilyas (লেখক), Muhammad Asif (লেখক), Minglian Wang (লেখক), Reem Altaf (লেখক), Hajra Zafar (লেখক), Mirza Muhammad Faran Ashraf Baig (লেখক), Ana Cláudia Paiva-Santos (লেখক), Muhammad Abbas (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...